<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109">
 <label>109.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qiu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Thongpoon</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Evaluation of 
   <italic>Plasmodium vivax</italic> HAP2 as a transmission-blocking vaccine candidate
  </article-title>. 
  <source>Vaccine.</source> (
  <year>2020</year>) 
  <volume>38</volume>:
  <fpage>2841</fpage>â€“
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2020.02.011</pub-id>
  <?supplied-pmid 32093983?>
  <pub-id pub-id-type="pmid">32093983</pub-id>
 </mixed-citation>
</ref>
